Session Information

  • WCLC 2021

    2021 World Conference on Lung Cancer

    Presentation Date(s):  
    • September 8 - 14, 2021
    • Total Presentations: 1107

    All times listed are in Mountain Time MDT (UTC-6:00)

    PL - Plenary
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    WS - Workshops
    IS - Industry Symposium
    MTE - Meet the Expert
    BEDG - Brain Exchange Discussion Groups

Filter Results:

Show Only CME Accredited Sessions

  • +

    FP11 - Patient Advocacy

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters (Featured)
    • Track: Patient Advocacy
    • +

      FP11.01 - Sustaining and Accelerating Research in Rare Oncogene-Driven Lung Cancers: Lessons From The 2020 ROS1der Research Roundtable

      00:00 - 00:00  |  Presenter: Janet Freeman-Daily

      • Abstract

      Loading...

  • +

    P60 - Predictive Tumor Based Assays/ Biomarkers/ Pathology - Other Biomarkers

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
    • +

      P60.14 - A United States Study Focused on Patients’ Understanding of, Attitudes Towards, and Barriers to the Use of Biomarker Testing for NSCLC

      00:00 - 00:00  |  Presenter: Upal Basu Roy

      • Abstract

      Loading...

  • +

    PL02 - Plenary 2: Presidential Symposium (Japanese, Mandarin, Spanish Translation Available)

    • 06:30 - 08:00
    • 9/09/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Plenary
    • Track: N.A.
    • +

      PL02.09 - International Association for the Study of Lung Cancer (IASLC) Study of the Impacts of COVID-19 on International Lung Cancer Clinical Trials

      07:38 - 07:48  |  Presenter: Matthew Smeltzer

      • Abstract

      Loading...

  • +

    MA05 - Using Real World and Patient Reported Data to Identify Gaps and Needs for People with Lung Cancer: Impacts of the COVID-19 Pandemic, Treatment Patterns, and Psychosocial Impacts

    • 08:15 - 09:15
    • 9/09/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Patient Advocacy
    • +

      MA05.05 - Treatment Patterns in Patients With EGFR-Positive Lung Cancer: A Real-World Patient-Report

      08:45 - 08:50  |  Presenter: Ivy B. Elkins

      • Abstract

      Loading...

  • +

    OA08 - Moving Beyond New Drugs: What Else Matters?

    • 09:30 - 10:30
    • 9/09/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Health Services Research/Health Economics
    • +

      OA08.01 - Trends in Within-Class Changes in US Prices of Drugs used for Metastatic Non-Small Cell Lung Cancer from 2015 to 2020

      09:30 - 09:40  |  Presenter: Aakash Desai

      • Abstract

      Loading...

    • +

      OA08.02 - First Line Treatment Patterns in Advanced NSCLC Patients With Compromised Performance Status or Comorbidities

      09:40 - 09:50  |  Presenter: Julia Judd

      • Abstract

      Loading...

    • +

      OA08.03 - The 5-year Survival Rate of Postoperative Non-small Cell Lung Cancer Patients with Two Different Follow-up Patterns

      09:50 - 10:00  |  Presenter: Daqiang Sun

      • Abstract

      Loading...

    • +

      OA08.04 - Validation of Scalable, Automated Data Extraction in an Advanced Lung Cancer Patient Population

      10:00 - 10:10  |  Presenter: Marie-pier Gauthier

      • Abstract

      Loading...

    • +

      OA08.05 - Discussant

      10:10 - 10:20  |  Presenter: Clarissa Baldotto

      • Abstract

      No abstract available for this presentation

    • +

      OA08.06 - Live Discussion with Speakers

      10:20 - 10:30

      • Abstract

      No abstract available for this presentation

  • +

    OA10 - Improving Care for People with Lung Cancer: Biomarker Testing Access, Psychosocial Distress, Care Navigation, and COVID-19 Vaccination

    • 10:45 - 11:45
    • 9/09/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Patient Advocacy
    • +

      OA10.01 - Perceptions of Biomarker Testing for Underserved Patients With Lung Cancer: A Mixed-Methods Survey of US-Based Oncology Clinicians

      10:45 - 10:55  |  Presenter: Leigh Boehmer

      • Abstract

      Loading...

  • +

    PL02A - Plenary 2: Presidential Symposium (Rebroadcast) (Japanese, Mandarin, Spanish Translation Available)

    • 14:30 - 16:00
    • 9/09/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Plenary
    • Track: N.A.
    • +

      PL02A.09 - International Association for the Study of Lung Cancer (IASLC) Study of the Impacts of COVID-19 on International Lung Cancer Clinical Trials

      15:38 - 15:48  |  Presenter: Matthew Smeltzer

      • Abstract

      Loading...